Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes

Author(s): Lanza IR, Zhang S, Ward LE, Karakelides H, Raftery D, et al.

Abstract

Insulin is as a major postprandial hormone with profound effects on carbohydrate, fat, and protein metabolism. In the absence of exogenous insulin, patients with type 1 diabetes exhibit a variety of metabolic abnormalities including hyperglycemia, glycosurea, accelerated ketogenesis, and muscle wasting due to increased proteolysis. We analyzed plasma from type 1 diabetic (T1D) humans during insulin treatment (I+) and acute insulin deprivation (I-) and non-diabetic participants (ND) by (1)H nuclear magnetic resonance spectroscopy and liquid chromatography-tandem mass spectrometry. The aim was to determine if this combination of analytical methods could provide information on metabolic pathways known to be altered by insulin deficiency. Multivariate statistics differentiated proton spectra from I- and I+ based on several derived plasma metabolites that were elevated during insulin deprivation (lactate, acetate, allantoin, ketones). Mass spectrometry revealed significant perturbations in levels of plasma amino acids and amino acid metabolites during insulin deprivation. Further analysis of metabolite levels measured by the two analytical techniques indicates several known metabolic pathways that are perturbed in T1D (I-) (protein synthesis and breakdown, gluconeogenesis, ketogenesis, amino acid oxidation, mitochondrial bioenergetics, and oxidative stress). This work demonstrates the promise of combining multiple analytical methods with advanced statistical methods in quantitative metabolomics research, which we have applied to the clinical situation of acute insulin deprivation in T1D to reflect the numerous metabolic pathways known to be affected by insulin deficiency.

Similar Articles

The early natural history of nephropathy in Type 1 Diabetes: III

Author(s): Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, et al.

The pathogenesis of diabetic nephropathy

Author(s): Dronavalli S, Duka I, Bakris GL

Patterns of renal injury in NIDDM patients with microalbuminuria

Author(s): Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, et al.

New and old markers of progression of diabetic nephropathy

Author(s): Jerums G, Premaratne E, Panagiotopoulos S, Clarke S, Power DA, et al.

Recent and potential developments of biofluid analyses in metabolomics

Author(s): Zhang A, Sun H, Wang P, Han Y, Wang X

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

Author(s): Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al.

A metabonomic comparison of urinary changes in Zucker and GK rats

Author(s): Zhao LC, Zhang XD, Liao SX, Gao HC, Wang HY, et al.

Scaling and normalization effects in NMR spectroscopic metabonomic data sets

Author(s): Craig A, Cloarec O, Holmes E, Nicholson JK, Lindon JC

Normalization of urinary drug concentrations with specific gravity and creatinine

Author(s): Cone EJ, Caplan YH, Moser F, Robert T, Shelby MK, et al.

Normalization strategies for metabonomic analysis of urine samples

Author(s): Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, et al.

Comprehensive profiling and quantitation of amine group containing metabolites

Author(s): Boughton BA, Callahan DL, Silva C, Bowne J, Nahid A, et al.

Proposed minimum reporting standards for data analysis in metabolomics

Author(s): Goodacre R, Broadhurst D, Smilde A, Kristal B, Baker J, et al.

A gentle guide to the analysis of metabolomic data

Author(s): Steuer R, Morgenthal K, Weckwerth W, Selbig J

Centering, scaling, and transformations: improving the biological information content of metabolomics data

Author(s): van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ

Multiple hypothesis testing

Author(s): Shaffer JP

Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations

Author(s): Miller RC, Brindle E, Holman DJ, Shofer J, Klein NA, et al.

Metabolite profiles and the risk of developing diabetes

Author(s): Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al.

Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study

Author(s): Merheb M, Daher RT, Nasrallah M, Sabra R, Ziyadeh FN, et al.

Preventive effect of taurine on experimental type II diabetic nephropathy

Author(s): Lin S, Yang J, Wu G, Liu M, Luan X, et al.